Cellectar Biosciences, Inc.
CLRB · NASDAQ
Bulios Fair Price
$1.54
35.3% downside
Trenutna cena
$2.38
Po podatkih Bulios Fair Price je delnica CLRB trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Cellectar Biosciences, Inc. is a biotechnology company focused on developing innovative drugs for the diagnosis and treatment of cancer. Their main product is a technology based on molecular probes that enable targeted detection and treatment of cancer cells. This technology is designed to increase the sensitivity and accuracy of cancer diagnostics and allow for selective therapeutic effects on tumor cells with minimal side effects. Cellectar Biosciences, Inc. is developing various products utilizing this technology, including diagnostic probes and therapeutic drugs, which may bring new options in cancer treatment and improve patient prognosis.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
James V. Caruso
Employees
11
Headquarters
Florham Park
Prihajajoči dogodki
Earnings
Upcoming earnings report